Crystal Formulations Services(CFS) Successfully Passed the EU QP Audit
more >Crystal Formulations Services(CFS) Accelerated Clinical Manufacturing of Jacobio's p53 Y220C Activator and Supported Early Patient Enrollment and Dosing
more >Crystal Formulations Services(CFS) Supported Accro Bioscience’s (Accropeutics) AC-201 Phase II Clinical Trial in China, Completing First Patient Dosing
more >Crystal Formulation Services (CFS) successfully obtained certifications in both Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) from SGS
more >Crystal Formulation Services Recognized as "Best Partner" by Allorion Therapeutics for Their Excellent Services
more >Crystal Formulation Services' GMP Manufacturing Facility Successfully Passed the Remote Audit by a US Client, Marking a Key Milestone for Its global Quality Management System
more >Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
more >